CoChat
Sign Up
Cited by 1,030Adenosine and Purinergic SignalingBiochemical and Molecular ResearchGout, Hyperuricemia, Uric Acid

The DOI matches its Crossref record; 744 of the 744 references it cites were found in a registry or an index.

Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation

Bours, M.J.L., Swennen, E.L.R., Di Virgilio, F., Cronstein, B.N., Dagnelie, P.C.·2006·Pharmacology & Therapeutics
DOI 10.1016/j.pharmthera.2005.04.013
Open this paper in CoChat — free account

Abstract

Human health is under constant threat of a wide variety of dangers, both self and nonself. The immune system is occupied with protecting the host against such dangers in order to preserve human health. For that purpose, the immune system is equipped with a diverse array of both cellular and non-cellular effectors that are in continuous communication with each other. The naturally occurring nucleotide adenosine 5'-triphosphate (ATP) and its metabolite adenosine (Ado) probably constitute an intrinsic part of this extensive immunological network through purinergic signaling by their cognate receptors, which are widely expressed throughout the body. This review provides a thorough overview of the effects of ATP and Ado on major immune cell types. The overwhelming evidence indicates that ATP and Ado are important endogenous signaling molecules in immunity and inflammation. Although the role of ATP and Ado during the course of inflammatory and immune responses in vivo appears to be extremely complex, we propose that their immunological role is both interdependent and multifaceted, meaning that the nature of their effects may shift from immunostimulatory to immunoregulatory or vice versa depending on extracellular concentrations as well as on expression patterns of purinergic receptors and ecto-enzymes. Purinergic signaling thus contributes to the fine-tuning of inflammatory and immune responses in such a way that the danger to the host is eliminated efficiently with minimal damage to healthy tissues.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2005.04.013

Cites

744 of 744 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Items 201–400 of 744

Flagged first, then by citations

Research works printed but not linked: 16

  1. Bowlin, 1995, Inhibition of NF-kappaB nuclear translocation and TNF-alfa gene expression by a novel adenosine A3 receptor agonist, Arthritis Rheum, 38, 1485
  2. Firestein, 1996, Anti-inflammatory effects of adenosine kinase inhibitors in acute and chronic inflammation, Drug Dev Res, 39, 371, 10.1002/(SICI)1098-2299(199611/12)39:3/4<371::AID-DDR18>3.0.CO;2-4 · DOI
  3. Fisette, 1996, Modulation of macrophage function by P2Y-purinergic receptors, Drug Dev Res, 39, 377, 10.1002/(SICI)1098-2299(199611/12)39:3/4<377::AID-DDR19>3.0.CO;2-Z · DOI
  4. Heath, 2003, Dangerous liaisons, Nat Immunol, 425, 460
  5. Huffnagle, 1997, Mechanisms of macrophage recruitment into infected lungs, Vol. 102, 373
  6. Jacobson, 1994, Characterization of the adenosine receptor subtype which mediates inhibition of TNF-alfa production in stimulated human monocytes, Drug Dev Res, 31, 282
  7. Khoa, 2003, Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells, J Immunol, 171, 3991, 10.4049/jimmunol.171.8.3991 · DOI
  8. Moore, 2001, Expression pattern of human P2Y receptor subtypes: a quantative reverse transcription-polymerase chain reaction study, Biochim Biophys Acta, 1521, 107, 10.1016/S0167-4781(01)00291-3 · DOI
  9. Moore, 2003, GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain microglia and peripheral immune cells, is regulated by immunological challenge: possible role in neuroimmune function, Mol Brain Res, 118, 10, 10.1016/S0169-328X(03)00330-9 · DOI
  10. Murphree, 2003, Lipopolysaccharide (LPS) induces the expression of A2a adenosine receptors in murine WEHI-3 macrophage-like cells, J Leukoc Biol Suppl, 26
  11. Peters-Golden, 1997, Lipid mediator synthesis by lung macrophages, vol. 102, 151
  12. Shanley, 1998, Adenosine receptor agonists inhibit macrophage inflammatory protein (MIP)-1alfa production in immunostimulated macrophages, FASEB J, 12, A766
  13. Szabo, 1998, Adenosine 3 receptor stimulation exerts potent anti-inflammatory effects in vivo, FASEB J, 12, A243
  14. Varani, 1998, Adenosine A2a receptors of human circulating blood elements, Drug Dev Res, 45, 253, 10.1002/(SICI)1098-2299(199811/12)45:3/4<253::AID-DDR23>3.0.CO;2-Q · DOI
  15. Zahler, 1998, Adhesion of neutrophils to cultured human endothelial cells is enhanced by stimulation of adenosine A1-receptors, Drug Dev Res, 45, 350, 10.1002/(SICI)1098-2299(199811/12)45:3/4<350::AID-DDR35>3.0.CO;2-L · DOI
  16. Zimmermann, 1996, Extracellular purine metabolism, Drug Dev Res, 39, 337, 10.1002/(SICI)1098-2299(199611/12)39:3/4<337::AID-DDR15>3.0.CO;2-Z · DOI

Cited by

Sorted by citations

See all 1,030

Related

See all

Metadata

Authors
Bours, M. J. L., Swennen, E. L. R., Di Virgilio, F., Cronstein, B. N., & Dagnelie, P. C.
Affiliations
  • Maastricht University (NL)
  • New York University (US)
Corresponding author
Bours, M.J.L.
ORCID
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2006-11
Volume
112
Issue
2
Pages
358-404
ISSN
0163-7258 (ISSN-L)
DOI
10.1016/j.pharmthera.2005.04.013
OpenAlex
W2042906495
Cited by
1,030
References
744
Citations by year
2026: 23 · 2025: 21 · 2024: 33 · 2023: 43 · 2022: 47 · 2021: 47 · 2020: 50 · 2019: 51 · 2018: 56 · 2017: 64 · 2016: 53 · 2015: 57 · 2014: 87 · 2013: 56 · 2012: 78
FWCI
2.33
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
  • Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
Keywords
adenosine 5'-triphosphate, adenosine, purinergic signaling, purinergic receptors, endogenous signaling molecules, immunity, inflammation, immune regulation, immunostimulation, immune cell types, ectoenzymes, extracellular nucleotides
MeSH terms
Adenosine, Adenosine Triphosphate, Humans, Immune System, Immunity, Cellular, Macrophages, Neutrophils, Signal Transduction, Apoptosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review